MUCIN-4 (MUC4) is a novel tumor antigen for pancreatic cancer immunotherapy

Pancreatic cancer (PC) is a highly lethal malignancy with a dismal five-year survival rate. This is due to its asymptomatic nature, lack of reliable biomarkers, poor resectability, early metastasis, and high recurrence rate. Limited efficacies of current treatment modalities and treatment-associated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Semin Immunol
Huvudupphovsmän: Gautam, Shailendra K, Kumar, Sushil, Dam, Vi, Ghersi, Dario, Jain, Maneesh, Batra, Surinder K
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160012/
https://ncbi.nlm.nih.gov/pubmed/31952903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2020.101391
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk